Three shareholders of Shandong Buchang Pharmaceuticals (SHA:603858) subsidiary Shandong Buchang Zhongxinkang Pharmaceutical Technology will sell their stakes to two individuals, according to a Tuesday filing with the Shenzhen bourse.
Chen Xuebo will divest his 2% stake in Zhongxinkang to Zhang Jiancan for 60,748 yuan, while Mao Xiaoteng and Gao Jinliang will sell each of their 1% stakes to Su Gui for 30,374 yuan each.
Zhang is a sales director at Shandong Buchang Zhenze Pharmaceutical Technology, while Su Gui is a director of third terminal sales at Zhongxinkang.